LumiThear's Valeda is an FDA-authorized treatment for dry age-related macular degeneration to improve vision. (LumiThera ...

Part of Alcon's motivations for continuing to pursue the lawsuit relates to an upcoming TV series based on the movie. The company expressed that it wants to distance itself from Tesla and Elon Musk.

Broadwood的代理文件聚焦STAAR的控制权变更支付，声称高管将获得超过5500万美元的加速股权奖励，其中包括首席执行官Stephen ...

STAAR Surgical Company’s (NASDAQ:STAA) contested sale to Alcon AG (NYSE:ALC) has escalated after its largest shareholder took the first formal step toward a proxy fight to defeat the $28-per-share ...

Broadwood’s filing marks the first organized campaign against the Alcon transaction. In its statement, Broadwood alleges that ...

Passive investing in an index fund is a good way to ensure your own returns roughly match the overall market. When ...

Investing.com - STAAR Surgical Company (NASDAQ:STAA)与Alcon AG (NYSE:ALC)之间有争议的出售交易升级，该公司最大股东正式采取第一步行动，发起代理权争夺战以阻止每股28美元的合并交易。

Alcon has announced its launch of the first fully personalized LASIK treatment, wavelight plus, in the US and Canada. 1 The ...

近日，来自英国的顶级刹车品牌ALCON通过其中国独家总代理GUSTO（格时图）宣布，搭载国产高性能碳陶制动盘的ALCON碳陶刹车套件正式在中国市场发售。这一消息无疑为高性能车爱好者带来了新的选择，也为整车性能提升提供了更多可能性。

Alcon launched wavelight plus, a personalized LASIK treatment, in the U.S. and Canada, according to a press release.

The pending sale of STAAR Surgical Company (NASDAQ:STAA) to Alcon Inc. (NYSE:ALC) has taken an unusual turn. In April 2024, the implantable lens maker rejected a $58-per-share takeover bid from Alcon.

OpZira Inc was formed after Alcon acquired LumiThera, with LumiThera's diagnostic products spun off to create the new company ...